Metabolic analysis of stem-cell enriched CD34+ and CD34+CD38− and differentiated CD34− cells from CML patients has also indicated that CML LSCs require upregulated oxidative metabolism for their survival [204]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.